Formidable Asset Management, LLC Surface Oncology, Inc. Transaction History

Formidable Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.61 - $1.03 $1,464 - $2,472	2,400 Added 18.79%	15,175 $11,000
Q4 2022 Feb 07, 2023	BUY	$0.62 - $1.21 $682 - $1,331	1,100 Added 9.42%	12,775 $10,000
Q3 2022 Nov 14, 2022	SELL	$1.05 - $2.1 $577 - $1,155	-550 Reduced 4.5%	11,675 $13,000
Q2 2022 Aug 16, 2022	BUY	$1.42 - $3.15 $1,526 - $3,386	1,075 Added 9.64%	12,225 $25,000
Q1 2022 May 04, 2022	BUY	$2.65 - $5.08 $29,547 - $56,642	11,150 New	11,150 $33,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Formidable Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Formidable Asset Management, LLC with notifications on news.